Literature DB >> 15887853

Dehydroepiandrosterone sulfate and bone resorption rates as reflected by serum levels of C-terminal telopeptide of type I collagen: a study in healthy men.

V Carnevale1, A Scillitani, E Vecci, E D'Erasmo, E Romagnoli, F Paglia, J Pepe, V Baldini, C Santori, S De Geronimo, S Minisola.   

Abstract

Sex steroid hormones contribute to the physiological regulation of bone turnover in males. To address this issue, we investigated serum estradiol (E2), total testosterone (T), and DHEAS concentrations, along with serum levels of carboxy-terminal telopeptide of type I collagen (sCTx), in a sample of 76 healthy men aged 23 to 87. The concentration of sCTx declined with age. Both T and DHEAS, at variance with E2, showed a significant age-related decline. T, DHEAS and sCTx significantly (p<0.01) correlated with each other. DHEAS and T were significantly associated after correcting for age (r=0.35, p=0.002) or body mass index (r=0.65, p<0.0001). DHEAS, but not T, significantly correlated with sCTx after correcting for age (r=0.26, p=0.026, and r=0.20, p=0.08, respectively). Stepwise multiple regression analysis showed that only DHEAS (but not T or E2) was a significant independent predictor of sCTx (p=0.0001). Our results show that adrenal androgens play a crucial role in regulating bone resorption in aging men.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15887853     DOI: 10.1007/bf03345350

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  23 in total

1.  Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men.

Authors:  S Khosla; L J Melton; E J Atkinson; W M O'Fallon
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

Review 2.  Clinical review 24: Androgens in the aging male.

Authors:  A Vermeulen
Journal:  J Clin Endocrinol Metab       Date:  1991-08       Impact factor: 5.958

3.  Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency.

Authors:  J P Bilezikian; A Morishima; J Bell; M M Grumbach
Journal:  N Engl J Med       Date:  1998-08-27       Impact factor: 91.245

4.  Gender differences in serum markers of bone resorption in healthy subjects and patients with disorders affecting bone.

Authors:  S Minisola; S Dionisi; M T Pacitti; F Paglia; V Carnevale; A Scillitani; S Mazzaferro; Geronimo S De; J Pepe; E Derasmo; E Romagnoli
Journal:  Osteoporos Int       Date:  2002       Impact factor: 4.507

5.  Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study.

Authors:  G A Laughlin; E Barrett-Connor
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

6.  Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia.

Authors:  C Y Guo; A P Weetman; R Eastell
Journal:  Clin Endocrinol (Oxf)       Date:  1996-11       Impact factor: 3.478

Review 7.  Clinical review 144: Estrogen and the male skeleton.

Authors:  Sundeep Khosla; L Joseph Melton; B Lawrence Riggs
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

Review 8.  DHEA treatment: myth or reality?

Authors:  Bruno Allolio; Wiebke Arlt
Journal:  Trends Endocrinol Metab       Date:  2002-09       Impact factor: 12.015

Review 9.  Men, bone and estrogen: unresolved issues.

Authors:  E S Orwoll
Journal:  Osteoporos Int       Date:  2003-03-04       Impact factor: 4.507

10.  Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells.

Authors:  M J Oursler; L Pederson; L Fitzpatrick; B L Riggs; T Spelsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.